TWiV 1360: Clinical Update with Dr. Daniel Griffin
In his weekly clinical update, Daniel Griffin and Vincent Racaniello frustration continues over the increasing number of measles infections, Kennedy's undermining of vaccines, perpetuation of autism- ...
26 Sep 1h
TWiV 1359: SSPE, the Long Shadow of Measles
Roberto Cattaneo and Kalpana Yadav join TWiV at the 2026 meeting of the American Society for Virology to discuss how the absence of measles virus receptors in the brain selects for hyperfusogenic vari...
20 Sep 1h 10min
TWiV 1358: Clinical Update with Dr. Daniel Griffin
In his weekly clinical update, Daniel Griffin and Vincent Racaniello are angered by the continuous reporting of measles deaths in the US and around the world, the Ebola outbreak in Uganda, changes in ...
19 Sep 53min
TWiV 1357: Furin, Naturally with Paul Bieinasz
Paul Bieniasz joins TWiV to discuss his lab's discovery that the coronavirus nuclease NSP15 cuts viral RNA into oligonucleotides that are reinserted elsewhere in the viral RNA, generating insertion mu...
13 Sep 1h 44min
TWiV 1356: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Daniel Griffin and Vincent Racaniello delve into dengue virus infections in Florida, recent human rabies infections in the US, proposed changes in biomedical funding inc...
12 Sep 47min
TWiV 1355: Four billion years of AI training data
TWiV reviews a landmark paper reporting the first generative design of complete viral genomes using AI, producing 16 viable bacteriophages that overcame antibiotic-resistant bacteria where natural pha...
6 Sep 1h 38min
TWiV 1354: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Daniel Griffin and Vincent Racaniello remember Dolly Parton and her patronage of science, especially development of the COVID-19 vaccines, if the shingles vaccine protec...
5 Sep 1h 5min
TWiV 1353: Phage bet-hedging and EBV antibodies
TWiV explores how bacteriophages enable bet-hedge against bacterial immune defenses, and how transgenic mice engineered to produce human antibodies yielded potent anti-EBV candidates targeting gp350 a...
30 Aug 1h 52min
